RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CORALLO S
Collezione AO Ordine Mauriziano

Items : 6

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study. in BMC cancer / BMC Cancer. 2024 May 6;24(1):563. doi: 10.1186/s12885-024-12328-0.

2024
AO Ordine Mauriziano

Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; et alii...

The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO). in Tumori / Tumori. 2024 Jun;110(3):203-208. doi: 10.1177/03008916231222761. Epub 2024 Feb 7.

2024
AO Ordine Mauriziano

Speranza D; Sapuppo E; Aprile G; Auriemma A; Bergamo F; Bianco R; Bordonaro R; Brandi G; Brunetti O; Carnaghi C; Ciliberto D; Cinieri S; Corallo S; De Vita F; Di Donato S; Ferraù F; Fornaro L; Barucca V; Giommoni E; Lotesoriere C; Luchini C; Masini C; Niger M; Pisconti S; Rapposelli IG; Rimassa L; Rognone C; Rodriquenz MG; Corsini LR; et alii...

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study. in BMC cancer / BMC Cancer. 2024 Apr 8;24(1):436. doi: 10.1186/s12885-024-12225-6.

2024
AO Ordine Mauriziano

Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study. in ESMO open / ESMO Open. 2021 Oct;6(5):100246. doi: 10.1016/j.esmoop.2021.100246. Epub 2021 Aug 17.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Bartolomeo M; Pietrantonio F; Di Maio M; Morano F; Corallo S; Berenato R; Ratti M; Clavarezza M; Zaniboni A; Murialdo R; Tampellini M; Ritorto G; Raimondi A; Fucà G; Leone AG; Lonardi S; Antoniotti C; Smiroldo V; Amatu A;

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2020 Mar 1;26(5):1017-1024. doi: 10.1158/1078-0432.CCR-19-3024. Epub 2019 Nov 18.

2020
AO Ordine Mauriziano

Milione M; Di Nicolantonio F; Tamborini E; Perrone F; Barault L; Macagno M; Martinetti A; Palermo F; Guarini V; Pagani F; Corallo S; Randon G; Gori S; Petrelli F; Farina G; Longarini R; Tomasello G; Sartore-Bianchi A; Murgioni S; Rimassa L; Mosconi S; Morano F; Raimondi A; Lonardi S; Antista M; Lobefaro R; Pietrantonio F; Di Maio M; Fucà G; et alii...

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Aug;135:230-239. doi: 10.1016/j.ejca.2020.04.048. Epub 2020 Jul 2.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pietrantonio F; Di Bartolomeo M; Peverelli G; de Braud F; Antista M; Niger M; Bergamo F; Cinieri S; Longarini R; Giordano M; Antonuzzo L; Petrelli F; Adamo V; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Ritorto G; Sartore-Bianchi A; Rimassa L; Antoniotti C; Corallo S; Lonardi S; Morano F; Raimondi A; Di Maio M; Raimondi A; Di Maio M; et alii...